Platform drug delivery system utilizing crystal engineering and theanine dissolution

• 收藏
• 分享

专利权人:

THEAPRIN PHARMACEUTICALS INC.

发明人:

Harry G. Brittain,Philip V. Felice

申请号：

US15097681

公开号：

US09603939B2

申请日:

2016.04.13

申请国别(地区):

US

年份:

2017

代理人:

摘要：

A method of treating Hodgkin's disease in a subject. The method involves administering to the subject an effective amount of a water-soluble composition which includes a cocrystal composition containing doxorubicin and a theanine enantiomer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/